Aram Ghalali

Aram Ghalali is an Instructor of Surgery and Faculty member at Harvard Medical School, affiliated with the Vascular Biology Program and Dana-Farber/Boston Children's Cancer and Blood Disorders Center. His research focuses on drug discovery for prostate cancer, medulloblastoma treatment targets, and vascular biology. He holds degrees from Karolinska Institutet (Ph.D. in cellular signaling) and Mälardalens University (Civil Engineering), with postdoctoral training in toxicology and cancer research.

Research Interests: High-throughput drug screening, pediatric brain tumors, oncoprotein biomarkers, and molecular signaling pathways. Current projects include NIH-funded collaboration on AZIN1's role in tumor suppression and Swedish Childhood Cancer Fond-supported medulloblastoma studies.

Grants & Collaborations: NIH grant (collaboration with Prof. Zetter and Dr. Rogers) and Swedish Childhood Cancer Fond grant. Research emphasizes translational applications for pediatric cancers and vascular disorders.

Labs & Teams: Active in the Zetter Research Laboratory and Vascular Biology Program at Boston Children’s Hospital. Contributions span preclinical models (mouse endometriosis pain), biomarker discovery, and FRET assay development.